Clinical trial · Observational
Association Between Cancer and Sarcoidosis
Outcome Study of Sarcoidosis: a New Paraneoplastic Syndrome in Patient With Cancer
NCT03844698CI-TRIAL-00058233completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to develop a clinical dataset of sarcoidosis patients with a diagnosis of cancer who are categorized by date of birth, sex, race/ethnicity, clinical information, laboratory and imaging information, time of sarcoidosis onset, cancer type and treatment, time of cancer diagnosis, stage and grade.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Sarcoidosis | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Patients with Sarcoidosis and Cancer
- description
- These group of patients have a diagnosis of Sarcoidosis and Cancer on the Pathological Report.
Primary outcomes (1)
- measure
- Pathology Proven Sarcoidosis In Patients with Cancer
- timeFrame
- up to 10 years
- description
- Number of Participants With Sarcoidosis Events as Assessed by Positive Granulomatous Reaction in the Biopsies of Lung, Mediastinal Lymph Nodes, or Other Organs After Cancer Diagnosis.
Secondary outcomes (2)
- measure
- Cancer Cytogenetics and Sarcoidosis
- timeFrame
- up to 10 years
- description
- Number of Participants With Sarcoidosis Events as Assessed by Cancer Cytogenetic Profiles of Cancer.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Clinical diagnosis of Sarcoidosis following cancer * Granulomatous reaction must be proven by pathology Exclusion Criteria: . Aged younger than 18 years old.
References
Publications (1)
- DERIVEDMurthi M, Yoshioka K, Cho JH, Arias S, Danna E, Zaw M, Holt G, Tatsumi K, Kawasaki T, Mirsaeidi M. Presence of concurrent sarcoid-like granulomas indicates better survival in cancer patients: a retrospective cohort study. ERJ Open Res. 2020 Oct 26;6(4):00061-2020. doi: 10.1183/23120541.00061-2020. eCollection 2020 Oct. PMID 33263026